Marked reduction of Tamm-HorsfaU protein synthesis in hyperprostaglandin E-syndrome. Hyperprostaglandin E-syndrome (HPS), a recently described variant of Bartter's syndrome (BS), resembles BS in a number of symptoms but is distinct from BS in others. Similar to BS, HPS is characterized by congenital hypokalemic alkalosis, hypertrophy of the juxtaglomerular apparatus, hyperreninemia, secondary hyperaldosteronism, normal blood pressure and renal diabetes insipidus. Other than BS, HPS is constantly associated with chronic hypercalciuria and nephrocalcinosis as well as both renal and systemic POE2 overproduction. Correction of most of the symptoms in HPS is achieved by permanent inhibition of prostaglandin synthesis with indomethacin. Among the causes leading to HPS, a selective damage of the distal tubule in HPS has been suggested. Therefore, synthesis of TammHorsfall protein (THP), a glycoprotein exclusively produced in the thick ascending limb of the loop of Henle, was measured by ELISA in the urine of seven infant HPS patients (aged 3 to 8 years). Patients were investigated both under constant indomethacin treatment and after a one week period without indomethacin. Nine healthy children (aged 5 months to 10 years) served as controls. In controls mean daily THP excretion was 54.2 13.9 (median 46.0) mg/24 hr/l .73 m2 whereas in HPS, THP levels were strongly diminished. During withdrawal of indomethacin treatment, mean THP level was 12.7
tion. Correction of most of the symptoms in HPS is achieved by permanent inhibition of prostaglandin synthesis with indomethacin. Among the causes leading to HPS, a selective damage of the distal tubule in HPS has been suggested. Therefore, synthesis of TammHorsfall protein (THP), a glycoprotein exclusively produced in the thick ascending limb of the loop of Henle, was measured by ELISA in the urine of seven infant HPS patients (aged 3 to 8 years). Patients were investigated both under constant indomethacin treatment and after a one week period without indomethacin. Nine healthy children (aged 5 months to 10 years) served as controls. In controls mean daily THP excretion was 54.2 13.9 (median 46.0) mg/24 hr/l .73 m2 whereas in HPS, THP levels were strongly diminished. During withdrawal of indomethacin treatment, mean THP level was 12.7
10.1 (median 7.2) mg/24 hr/1.73 m2 and 10.3
10.1 (median 3.5) mg/24 hr/i .73 m2 under indomethacin treatment, respectively. THP excretion values both without indomethacin and under indomethacin treatment were significantly different from controls (P 0.005); however, there was no significant difference between the THP levels during or after cessation of indomethacin treatment. Creatinine clearance in HPS patients was 75.1 15.9 (median 76.2) ml/minll .73 m2 without indomethacin and 81. revealed normal THP values in two individuals and intermediate levels in the others: the mean level of six BS patients was 30.8 13.5 (median 25.0) mg124 hr/1.73 m2 and was thus significantly higher than in HPS both with and without indomethacin treatment (P 0.05). Immunohistochemistry in renal biopsies of three of the HPS patients showed a strong reduction of cortical tubular THP immunoreactivity in two cases and a less pronounced reduction in the third. In situ hybridization using a THP-riboprobe in these three biopsies revealed significantly reduced or absent THP-mRNA levels. The severely decreased THP-production supports previous assumptions that one of the major causes underlying HPS is a selective congenital defect of the distal tubule. Differences in THP excretion between HPS and BS support a concept that defines distal chloride reabsorption is not altered [4] , and chronic hypercalciuria is established [3] . Polyhydramnion and premature birth indicate a prenatal onset of this syndrome. Additional prostaglandin-mediated systemic complications like osteopenia, fever, secretory diarrhea and an increased susceptibility to infection are present in HPS. Correction of most symptoms is achieved by a constant indomethacin treatment [4, 6] .
Striking similarities between HPS symptoms and chronic furosemide intake (such as, sodium wasting, renal diabetes insipidus, loss of potassium and enhanced calciuresis) [7] , indicate a selective defect of the distal tubule. Since TammHorsfall protein (THP) is thought to be related to the function of the thick ascending limb of the ioop of Henle [8] [9] [10] [11] , the present study was undertaken to investigate THP synthesis in HPS. THP is the most abundant protein in normal urine with a daily excretion rate of 50 to 100 mg/24 hr [12] . It is synthesized exclusively by the epithelial cells of the thick ascending limb with exception of the macula densa [10, 11, 13] . Though its physiological role has not yet been understood, THP location in the thick ascending limb suggests that this glycoprotein might be involved in sodium or chloride transport [14] [15] [16] or in maintaining the low water permeability of the thick ascending limb [9] . Other hypothetical roles of THP concern the prevention of bacterial adhesion along the urinary tract [17] , an immunoregulatory function due to its influence on the biological activity of cytokines [18] , as well as an involvement in the prevention of renal calcium oxalate stones [19] .
This paper reports urinary THP levels measured by ELISA in infants with HPS and BS respectively, as well as in healthy infant controls. Immunohistochemistry and in situ hybridization histochemistry were used to show the distribution and production of THP in renal biopsies of three of the HPS patients. 
Methods
Patients with hyperprostaglandin E-syndrome Three male and four female HPS patients (aged 3 to 8 years, mean 5.10/12 years) were investigated. HPS was diagnosed based on polyhydramnion, premature birth (mean 30.4 weeks), elevated urinary PGE2 and PGE-M levels, and hypercalciuria with nephrocalcinosis. Patient history showed a maternal history of frequent spontaneous abortions in five cases. THP in HPS patients was measured under constant indomethacin treatment and after a one week period without indomethacin. Renal biopsies of three of the HPS patients were available (Prof.
Waldherr, Heidelberg, Germany). Biopsies had been performed approximately three years before the present investigation of urinary parameters and had since been stored at -70°C. Urine was stored at -20°C.
Patients with Bartter's syndrome For comparison of THP levels, the urine of six patients diagnosed with classical BS was studied. These patients (aged 3 months to 17 years, mean 10.10/12 years; five males, one female) showed the typical clinical symptoms of BS such as hypokalemia, metabolic alkalosis, hyperreninemia and secondary hyperaldosteronism.
Controls
Urine of nine healthy children (aged 5 months to 10 years, mean 6.1/12; 4 males and 5 females) was also analyzed. These children had no history of hypertension, diabetes, or urinary tract infection. Urine was screened and found negative for nitrite, proteins, glucose, ketone bodies, urobiinogen, bilirubin, blood and hemoglobin by Combur 8-Test©. Urinary pH was within normal range.
Urine collection
Twenty-four hour urine collections were performed using PVC containers suitable for collection of THP [20] . Urine was stored at 4°C during the collection procedure and subsequently frozen in aliquots of five ml and stored at -20°C. Samples from foreign hospitals were collected correspondingly and sent in frozen CO2. Urinary creatinine was used to control the correctness of collection; 24 hour creatinine excretion per kilogram body weight was considered to be relatively constant, that is to vary slightly with alimentation, activity and diuresis. There was no significant difference in creatinine values between the groups. Quantification of urinary THP by ELISA Urinary THP was isolated by repeated precipitation from pooled normal human urine with 0.58 M NaCI according to the method of Tamm and Horsfall (1950) [211. Purity of the isolated standard was established by SDS-polyacrylamide gel electrophoresis using a gradient of 4 to 12% (wt/vol). Gels were stained with Coomassie blue. Immunoblotting was performed by transfer to a blot membrane (Immobilon, Millipore, Eschborn, Germany) which was subsequently incubated with monoclonal mouse-anti-human THP antibody (Cedarlane Lab., Hornby, Canada), dilution 1/1000 wt/vol in phosphate buffered saline with 1/500 vol/vol Tween 20 (Merck, MUnchen, Germany) [PBST] . For detection, an alkaline phosphatase-conjugated anti-mouse antibody (Amersham, Braunschweig, Germany; dilution 1/500 vol/vol in PBST) was used. Both SDS-gel electrophoresis and Western blot showed a single band at approximately 90 kilodalton. For measuring THP in urine, an ELISA was established with the first antibody bound to the solid phase (monoclonal mouse-anti-human THP, Cedarlane Lab., Hornby, Abbreviations are: PGE2, Prostaglandin E2; PGE-M, 7a-hydroxy-5, I 1-diketotetranorprostane-1 ,16 dioic acid (major urinary metabolite of systemic E-prostaglandins); THP, Tamm-Horsfall protein; Car, creatinine clearance; ND, not determined. Normal range 50 to 100 500 to 2000 20 to 90
Canada; 0.5 ttgiml bicarbonate buffer, pH = 9.4), a second biotinylated antibody (polyclonal rabbit-anti-human-THP antibody, Behring, Marburg, Germany; 2 c.tg/ml PBST, pH = 7.4) and a streptavidin-peroxidase detection system (Amersham; dilution 0.5 .d/ml PBST). Microtiter plates (96 wells) were from NUNC (Wiesbaden, Germany). Sensitivity of the test was sufficient to allow for strong dilutions of the urine probes in water. Dilution of the samples was considered an essential step for disaggregation of clots of THP polymers [22] . Serial dilutions from 1/12.5 to 1/100 in distilled water were chosen depending on the amount of diuresis of each individual. Purified human THP was used to establish a standard curve ranging between 2.35 and 300 nglml. The curve demonstrated a sensitivity of the test down to a concentration of 9.4 ng/ml and linearity between 70 and 300 ng/ml. Urine samples were frozen and diluted with distilled water just prior to assay. Standard THP and samples were further double-diluted in PBST in order to verify parallelism with the standard curve. In samples with very low THP concentrations (<70 ng/ml) parallelism of the dilutions to dilutions of the standard could not be established; therefore, THP values in these samples were estimated. Intertest variability was usually below 15%, intra-test variability was below 5% (P < 0.05).
Evaluation of other urinary parameters
Excretion rates of PGE2 and PGE-M (7a-hydroxy-5, 11-diketotetranorprostane-1,1 6-dioic acid) were determined as described previously [23, 24] . Excretion rates of PGE2 were thought to reflect renal, and PGE-M to reflect total body prostaglandin production [25] . Urine osmolality was determined using a freezing point depression osmometer. For the determination of urine electrolytes and creatinine, routine laboratory methods were adopted. Values of the measurements are given both as means standard deviation and as medians.
Iintnunohistochemistry on kidney biopsies For immunohistochemical detection of THP, renal biopsies (punch biopsies) of the HPS patients number two, four and five were sectioned in a cryostat microtome. Alternate sections were used for immunohistochemistry and in situ hybridization (see below). Treatment of the sections for immunohistochemistry included incubation with the same monoclonal anti-THP antibody used in the ELISA at dilutions of 1/50 and 1/200 in phosphate buffered saline (PBS) (vol/vol) containing 1% (wt/ vol) of bovine serum albumin and detection of the bound antibody using a second FITC (fluorescein isothiocyanate)-labeled antibody at a dilution of 1/40 in bovine serum albumin (BSA)/PBS (vollvol). Sections were viewed in a Reichert Polyvar microscope using an HBO 200 watt lamp.
In situ hybridization on kidney biopsies For in situ hybridization, cryostat sections were mounted on glass slides coated with poly-L-lysine (Sigma; 100 g/m1 in bidistilled water). Sections were fixed for 30 minutes in 4% paraformaldehyde in PBS, pH = 7.4 and stored in 70% ethanol at 4°C until further use. For hybridization, a 1.98 kb Eco Rl human kidney uromodulin cDNA fragment obtained by Dr.
Alan Shaw from Glaxo (Geneva, Switzerland) was used. A 665 base pair BamHIfHincII fragment (from position 681 BamHI to position 1346 HincIl) of the original probe was subcloned into the BamHI site of the pGEM-4 transcription vector permitting the generation of sense and antisense riboprobes (R. Metzger, Heidelberg, Germany). Transcription and hybridization procedures were as described previously [Ii] . Briefly, in vitro transcription of the probes was carried out under incorporation of t35S]-a-labeled UTP (Dupont NEN; sp. act. 1350 Ci/mmol). For in situ hybridization, alternate sections were used for sense and antisense probe hybridization. Activity of the probes used for hybridization was approximately 3000 and 10000 dpm/d, respectively. Slides were washed in 1 x standard saline citrate (SSC)/S0% formamide at 48°C for six hours. The washing solution was changed every 90 minutes. Two final high stringency washes were carried out with either 0.5x or 0.ix SSC, each for 10 minutes at room temperature. The slides were dipped in a 50% aqueous solution of photographic emulsion NTB-2 (Eastman Kodak, Rochester, New York, USA) at 45°C, exposed at 4°C, developed with D19 developer (Kodak) and fixed with Unifix (Kodak). The time of exposure of the slides was either five, 15 or 27 days. Sections were viewed in a Reichert Polyvar microscope using interference contrast optics.
Results

Urinary parameters
Urinary parameters such as THP excretion, diuresis, osmolality and calcium level are compared between healthy control children (N = 9, mean age 6.1/12 years) and HPS patients (N = 7, mean age 5.10/12 years) with and without indomethacin treatment (Table I, Fig. 1 ). Patients were under constant indomethacin treatment that was interrupted for a one week's period in order to establish drug-mediated influences. For comparison, THP was also determined in the urines from patients with classical BS (N = 6, mean age 10.10/12 years).
The mean daily THP excretion of the normal control population was 54. 2 13.9 mg/24 hr corrected to 1.73 m2 body surface area. The median of these samples was 46.0 mg/24 hr/i .73 m2; the range was between 41.5 and 85.4 mg/24 hr/i .73 m2. HPS patients excreted significantly lower amounts of THP: after the one week period of omission of indomethacin therapy, mean THP excretion was i2.7 10 Urinary prostaglandin E2 (PGE2) levels were strongly elevated in HPS patients without indomethacin (122. ;._ "a.
V.
-. Fig. 2a,b) but was focally present at normal strength in the thick ascending limbs in HPS patient 4 ( Fig. 2c ). For comparison, normal THP immunoreactivity from intact human renal tissue is shown in Figure 2d . These findings were reflected in the sections treated by in situ hybridization; no THP mRNA was detected in biopsies from patients two and five (Fig. 3a) , whereas in patient HPS 4, a focally weak expression of THP mRNA was found (Fig. 3b) . Again for comparison, normal THP mRNA expression is shown in thick ascending limb segments from the cortex of an intact adult human kidney revealing a stronger signal than that in patient HPS 4 (Fig. 3c) . Duration of exposure was the same in all specimens shown. Presence of thick ascending limb segments in all three biopsies was carefully controlled by counterstaining with hematoxylin-eosin, which allowed the identification of cortical medullary rays containing the straight parts of the nephrons. In the healthy kidney, thick ascending limb segments of the medullary rays revealed the strongest THP mRNAexpression [11] . Figure 4 shows a representative overview of a histologically stained, THP-negative biopsy (patient HPS 5) to demonstrate that the majority of nephrons in the biopsies was histologically intact. However, this observation does not exclude that interstitial calcifications and abnormalities at the cellular level may exist.
Discussion
The present data provide evidence for markedly reduced urinary production of Tamm-Horsfall protein in seven infant patients with hyperprostaglandin E-syndrome as assessed by a newly adapted ELISA. So far, this is the first study to report a significantly lowered THP production that is not simply caused by a reduction of the number of functioning nephrons. Patients with HPS revealed a moderately reduced creatinine clearance (median 83.0 mi/minI! .73 m2 under indomethacin treatment), however, this degree of reduction is not likely to account for the drastic fall in THP production reaching median values between one-tenth and one-twentieth of control THP levels. Generally, urine THP levels are known to be proportionately diminished with reduced GFR [8] . On the other hand, however, in adult patients with reduced kidney function, urinary THP levels were measured that were markedly higher than in HPS despite a median creatinine clearance as low as 26 mi/mm [81. In this respect, Grant and coworkers [26] stated that in patients with renal impairment, there was no reduction in THP excretion per unit of functioning nephron. Thus, HPS apparently represents an exception regarding the unproportionately low THP production that is paralleled by only moderate reduction in OFR.
In order to demonstrate that the low THP levels in HPS patients were not due to false determination by ELISA, three points should be raised. Firstly, problems in the immunological quantification of THP may stem from the specific physicochemical nature of the molecule which tends to form large aggregated polymers that may reduce antibody detection.
Therefore, we had to dilute urine samples to a high degree, a step that leads to disaggregation of the glycoprotein [22] .
Secondly, structural alterations of THP were reported in various disease states including disorders of calcium metabolism [19, 20] that may alter the conditions of THP determination. Accordingly, it may be argued that molecular alterations of THP in HPS may have led to the low urinary THP values determined. However, using the standard salt precipitation technique (0.58 M NaC1) originally applied by Tamm and Horsfall (1950) [21] to isolate a crude THP fraction from urine, we found that very little THP precipitate was obtained from HPS urines as compared to controls (Greven, unpublished observation). Thirdly, the biopsies analyzed for THP expression by in situ hybridization and immunohistochemistry revealed an almost complete absence of THP transcription and translation product at the site of THP production, that is, the thick ascending limb of the loop of Henle. Thus, we may conclude that HPS is associated with a defect of THP synthesis at the most proximal level of its mRNA transcription. These points taken together, we assume that the THP excretions measured by ELISA reflect an essential defect in THP synthesis in HPS.
Regarding a possible link between the lack of THP and an impairment in thick ascending limb function, a relationship between the Na, K, Cl-cotransporter located in this segment and THP has previously been discussed basing on interactions of the glycoprotein with loop diuretics [14, 15, 271 . However, other epithelia that possess the Na, K, Cl-cotransporter do not express THP [28] . On the other hand, the deficiency of the glycoprotein as a cell coat might affect the maintenance of water tightness of the thick ascending limb [9] , thus leading to an insufficient medullary concentration gradient. Lack of the cell coat may as well interfere with the segment's capacity for solute absorption by influencing the lumen-positive electrochemical gradient which constitutes the driving force for solute absorption in the thick ascending limb [29] .
A defect in sodium and chloride reabsorption in the thick ascending limb has been considered a "proximate cause" [2, 30, 31] [2, 32, 33] , increased levels of prostaglandin B2 [34] as well as hypercalciuria [33, 35] , the latter being characteristic for HPS. Particularly, premature infants receiving furosemide developed renal medullary calcifications [7] . Thus, it appears as if in HPS a maximally stimulated "endogenous furosemide-like loop diuretic" would be active that points to the thick ascending limb as the crucial source of the disorder. Interestingly, a remarkable resistance to furosemide therapy has recently been observed in children with HPS (Seyberth, unpublished observation).
Whether the lack of THP production represents a primary defect or whether it is merely a consequence of altered tubular electrolyte transport or of deteriorated tubular structure, remains to be discussed. A previous study has shown that in rats, THP urinary production appears to be constitutive in nature, as THP levels revealed no or only inconspicuous changes in different physiological and pathophysiological conditions altering the transport activity of the thick ascending limb [16, 36] . These findings were paralleled by a study in humans where different states of diuresis were not accompanied by significant changes in THP urinary excretion [37] . Therefore, altered electrolyte transport conditions are not likely to be responsible for suppressed THP in HPS.
On the other hand, the early onset of an altered calcium metabolism, which is known to cause cell injury [38] , may be responsible for a tubular defect. Since focal tubular and interstitial fibrosis as well as tubular atrophy were described in selected biopsies from HPS patients [5] , these damages together with varying extents of nephrocalcinosis may influence both solute reabsorption and THP production. But since overall renal structure of our biopsy material was not significantly deteriorated and accordingly, creatinine clearance of the HPS patients was at the lower normal range, THP underproduction is not likely to be derived from renal structural damage.
Related to renal concentrating defect and nephrocalcinosis, children with classic BS were an appropriate control group. Urine from BS patients contained significantly higher THP levels than that in HPS patients. Even if both disorders share a number of basic features, it has been proposed previously that-based on clinical and pathophysiological differences between HPS and BS-both syndromes may represent distinct pathological entities [4, 5, 39] . Regarding thick ascending limb function, symptoms in either disease differ with respect to distal chloride reabsorption, which is present in BS but not in HPS [4] , and in severe calcium malabsorption which is observed in HPS, but not in BS. However, the question whether the cause for the difference in THP excretion is based on fundamental differences between HPS and BS in thick ascending limb damage, cannot be fully answered by the present data. In HPS, a primary disorder of the thick ascending limb may cause the observed lack in THP production which is possibly related to the early onset of HPS symptoms in intrauterine life. In BS, where the onset of the disorder normally occurs later in childhood or in adulthood, abnormal renal growth and development is less likely to occur, and damage to the thick ascending limb may not be of comparable extent. Phenomenologically, however, the difference in THP urinary excretion supports the concept that BS and HPS represent two different pathological entities.
The reason why THP excretion in patients with Bartter's syndrome was somewhat lower than in controls (statistical significance P = 0.045), is not clear. Creatinine clearance levels were not available from these patients and thus, the degree of a possible structural degradation of the kidney could not be determined. However, former salt precipitation experiments have revealed that BS patients excrete rather normal THP levels (Greven, unpublished observations). Low THP levels in some of the BS patients may also stem from possible sampling errors, as urine collections from BS patients came from various different places and were not as closely monitored as those from HPS patients.
The primary defect of HPS cannot be clarified by the present study. It remains to be determined whether HPS is the consequence of a single tubular disorder, or rather the phenotype of a variety of tubular defects. The drastically elevated renal and systemic prostaglandin (PG) levels in HPS appearing in early infancy [4] exert a number of complex effects which may explain the majority of symptoms characteristic for HPS, like polyuria, isostenuria and impairment of solute handling [4, 40, 41] . However, since indomethacin treatment sufficiently blocks PG overproduction, it appears likely that the remaining disorders in HPS are PG-independent or at least do not directly depend on PG's. Thus, the observed deficiency in THP synthesis with or without indomethacin treatment, in concert with persisting polyuria and renal calcium leak, points to a selective defect of both the medullary and the cortical thick ascending limb of Henle's loop.
